Summary
Do you need pre-clinical tumor models that represent the diversity of the patient population? Using patient-derived xenograft (PDX) mice enables modeling the heterogeneity of human cancer and conducting more translationally-relevant cancer research studies.
In this webinar, you will learn about:
- A collection of more than 400 PDX models that have been established in partnership with a consortium of cancer hospitals and clinical trial teams
- How the genetics, pathology, and treatment response of PDX tumors reflect clinical observations
- Using tumor-bearing humanized NSG™ mice as an innovative platform to evaluate therapies
- Finding relevant cancer models and characterization data using the "Mouse Models of Human Cancer Database"
JAX™ Webinars are complimentary.
No fees will be charged for registering.
When registering, please use an institutional (e.g. work, university, etc.) email address or contact
our webinar staff to request an exception. Thank you.
